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Abstract
Background: Hyaluronan synthases (HAS) control the biosynthesis of hyaluronan (HA) and critically modulate the tumor
microenviroment. Cancer-associated fibroblasts (CAFs) affect the progression of a tumor by remolding the matrix.
However, little is known about the role of HAS from CAFs in this process. This study aimed to determine the role of
hyaluronan synthase 2 (HAS2) from CAFs in the progression of oral squamous cell carcinoma (OSCC) invasion.
Methods: HAS isoforms 1, 2, and 3 in paired sets of CAFs and normal fibroblasts (NFs) were examined by real-time PCR,
and the expression of HAS2 and α-SMA in OSCC tissue sections was further evaluated using immunohistochemical
staining. Furthermore, we used a conditioned culture medium model to evaluate the effects of HAS2 from CAFs on the
invasion and epithelial-mesenchymal transition (EMT) of the oral cancer cells Cal27. Finally, we compared the expression
of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) between CAFs and NF, and
between CAFs with or without HAS2 knockdown using an antibody array and western blotting.
Results: CAFs expressed higher levels of HAS2 than the paired NFs. HAS2 expression was consistent with α-SMA-positive
myofibroblasts in the stroma of OSCC, and these were significantly correlated advanced clinical stages and cervical
lymph node metastasis. Knocking down HAS2 with a specific siRNA or treatment with a HAS inhibitor markedly
attenuated CAF-induced invasion and EMT of Cal27 cells. Higher MMP1 and lower TIMP1 levels were detected in the
supernatants of CAFs relative to NFs. Knocking down HAS2 could decrease the expression of MMP1 and increase that of
TIMP1 in CAFs.
Conclusions: HAS2 is one of the key regulators responsible for CAF-mediated OSCC progression and acts by
modulating the balance of MMP1 and TIMP1.




1Jiangsu Key Laboratory of Oral Diseases, Nanjing Medical University, 136
Hanzhong Road, Nanjing 210029, Jiangsu Province, China
2Department of Oral and Maxillofacial Surgery, Affiliated Hospital of
Stomatology, Nanjing Medical University, 136 Hanzhong Road, Nanjing
210029, Jiangsu Province, China
Full list of author information is available at the end of the article
© The Author(s). 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Zhang et al. Journal of Experimental & Clinical Cancer Research  (2016) 35:181 
DOI 10.1186/s13046-016-0458-0
Background
Oral squamous cell carcinoma (OSCC) is prone to me-
tastasis through lymphatic channels, which leads to
cancer-related mortality and an unfavorable prognosis [1].
During this intricate process, the malignant epithelial cells
interact with the adjacent stromal cells and the extracellu-
lar matrix (ECM) to support their migration and invasion.
Cancer-associated fibroblasts (CAFs), which are also
known as myofibroblasts and are characterized by α-
smooth muscle actin (α-SMA) expression, are the stromal
cells involved in producing a tumor cell niche in coordin-
ation with other cell types such as macrophages to fuel
cancer overgrowth and spreading [2]. Accumulating evi-
dence has revealed that CAFs can be used as a reliable
marker to predict tumor progression and metastasis in
various human cancers [3–8]. Our preliminary study has
suggested roles for CAFs in cancer metastasis and the sur-
vival of patients with OSCC and suggested that the α-
SMA-positive myofibroblasts in OSCC facilitate the
epithelial-mesenchymal transition (EMT) and formation
of the pro-metastatic microenvironment [9]. However, the
underlying mechanisms that are responsible for CAF-
mediated OSCC dissemination remain unknown.
In contrast to normal fibroblasts (NFs), CAFs are able
to secrete a broad spectrum of bioactive molecules in a
paracrine manner. These molecules promote the growth
and invasion of tumor cells [10–13]. Matrix metallopro-
teinases (MMPs) are bioactive enzymes that are differen-
tially produced by these two types of fibroblasts [11, 14].
It has been established that MMPs degrade certain sub-
strates that regulate cell-cell adhesion and cell-matrix
adhesion and that this process is crucial for tumor cell
migration and EMT [15]. Recent studies have revealed
that MMPs and the natural endogenous tissue inhibitors
of metalloproteinases (TIMPs) orchestrate the multiple
diverse steps of tumor progression [16, 17]. Further-
more, the subtle balance between MMPs and TIMPs in
the tumor microenvironment plays vital roles in tumor
invasion and metastasis.
Hyaluronan (HA) is a glycosaminoglycan component of
the extracellular matrix that mediates microenvironmental
signals [18]. Three members of Hyaluronan synthase fam-
ily (HAS1, HAS2 and HAS3) dictate the biosynthesis of
HA and are critical for embryonic development, tumori-
genesis and inflammation [19]. These enzymes have been
reported to affect the patient outcome in numerous can-
cers by modulating the activities of MMPs and TIMPs
[20, 21]. For example, up-regulation of HAS2 in breast
cancer promotes the invasive potential of tumor cells by
suppressing TIMP1 [22]. Inhibition of HAS2 and/or
HAS3 decreased the invasion by colon carcinoma cells,
probably by inducing both the expression and activity
of MMP-7 [23]. These studies emphasize that HAS-
mediated regulation of MMPs and TIMPs is a critical
factor that affects the function of these proteins in
cancerous cells. However, these processes are largely
undefined in the tumor stromal cells. Thus, it was of
great interest to determine whether HAS isozymes
from CAFs influence the invasion and EMT of the
OSCC by affecting the balance of MMPs and TIMPs
in the tumor microenvironment.
In this study, we investigated whether HAS from CAFs
influenced the invasion and EMT of the OSCC and de-
termined the potential molecular mechanisms that
underlie this process. We first confirmed that the HAS2
expression is higher in CAFs by comparing the levels of
HAS1-3 in the paired CAFs and NFs from three different
OSCC patients. We then analyzed the relationship be-
tween HAS2 expression in the tumor stroma and clinical/
pathological characteristics of the OSCC. Furthermore, we
investigated the effects of HAS2 on CAF-induced migra-
tion, invasion and EMT of OSCC using an in vitro condi-
tioned culture medium system. Our findings indicated
that HAS2 is one of the key regulators responsible for
CAF-mediated OSCC progression and that it acts by
modulating the balance between MMP1 and TIMP1.
Methods
Patients and specimens
Between January 2011 and October 2013, a total of 48
patients with primary OSCC underwent radical resec-
tions at our hospital. Sixteen of the patients provided
paired adjacent non-cancer oral mucosa from the nega-
tive surgical margins. The primary sites of the OSCC
were the tongue (n = 20), buccal mucosa (n = 11), gingiva
(n = 12) and oral floor (n = 5). All of the surgical speci-
mens were reviewed and analyzed after the study proto-
col was approved by the ethics committee of Nanjing
Medical University.
Immunohistochemistry
The paraffin-embedded specimens were sectioned at
5 μm thickness, and the sections were baked at 37 °C
overnight. After deparaffinization using xylol and rehy-
dration with a graded series of ethanol solutions, the
sections were treated with 3% H2O2 plus 1% triton in
paraformaldehyde for 10 min at room temperature
followed by incubation with normal goat serum (Boster,
Wuhan, China) for another 30 min. Next, the sections
were incubated with primary antibodies for α-SMA and
HAS2 (Abcam, Cambridge, MA, USA) at 4 °C overnight.
After being washed in phosphate buffered saline (PBS), a
Polink2-plus reagent kit (Zhongsan Jinqiao Biotechnology,
Beijing, China) was used to detect the bound antibodies.
Finally, the slides were stained with 2% 3,3-diaminobenzi-
dine (DAB, Zhongsan Jinqiao Biotechnology) in 50 mM
Tris-buffer (pH 7.6) containing 0.3% hydrogen peroxide.
The slides were counterstained with Meyer’s hematoxylin.
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The negative controls were prepared by replacing the pri-
mary antibody with PBS. The immunostaining results
were evaluated independently by two researchers.
Evaluation of immunoreactivity
HAS2 and α-SMA immunostaining were initially evalu-
ated under low-power magnification to identify several
areas with relatively high staining. Subsequently, high-
power magnification was used to evaluate the tumor
stromal cells in each section. The expression of HAS2
and α-SMA was graded according to the percentage of
positive cells: low (<25%) and high (≥25%). The final re-
sults were determined by the highest grade of each slice.
Cell culture
Fresh tissues were obtained from 3 patients with OSCC
(one each from the tongue, gingiva and buccal mucosa)
who underwent radical surgical resection at our hospital.
The fresh cancer tissues were used to obtain primary
CAFs and the corresponding normal mucosa was ex-
cised at the negative margin to obtain paired primary
NFs. Briefly, the fresh tissues were sliced to 1 mm3 sizes,
dispersed into a culture flask, and allowed to adhere for
3 h. The tissue blocks were then maintained in DMEM
supplemented with 10% fetal bovine serum (FBS) until the
cells grew into confluent monolayers. After 2–3 passages,
the purified fibroblasts were retained and used for this
study before their 5th passage. The oral cancer cell line
Cal27 was obtained from American Type Culture Collec-
tion (ATCC) and cultured in DMEM/F12 medium with
10% FBS at 37 °C in an atmosphere containing 5% CO2.
Quantitative real-time PCR
The total RNA of the cells was extracted using TRIzol
reagent (Invitrogen, San Diego, CA, USA). The reverse
transcription to cDNA was carried out using the Prime-
Script RT kit (TaKaRa Holdings, Inc., Kyoto, Japan). The
primers, Taqman probes and SYBR Premix Ex Taq™ were
from TaKaRa. The amplification of the target genes was
performed according to the manufacturer’s protocols.
The relative expression of each target gene was normal-
ized to the level in the control samples using the com-
parative 2-ΔΔCT method. The primer sequences (forward
and reverse) are listed in Additional file 1: Table S1.
Western blotting
The harvested cells were lysed on ice for 30 min in RIPA
Lysis Buffer (Beyotime, Shanghai, China) containing
100 mM PMSF (Beyotime) and centrifuged at 12000 × g
for 5 min. The protein lysate supernatants were mixed
with loading buffer, separated by SDS-PAGE and trans-
ferred to polyvinyldifluoride membranes (Millipore
Corporation, Billerica, MA, USA). The final amount of
protein loaded in each well was 20 μg. The membranes
were blocked with 5% non-fat milk at room temperature,
incubated with primary antibodies at 4 °C overnight,
washed in PBST and incubated with the secondary per-
oxidase-conjugated antibodies. Finally, the protein bands
on the membranes were visualized using chemilumines-
cence reagents (WBKLS0100; Millipore Corporation, Bil-
lerica, MA, USA). The supplier and the specifications of
each primary antibody were as follows: rabbit anti-HAS2
monoclonal antibody and goat anti-TIMP-1 polyclonal
antibody (Santa Cruz Biotechnology, Santa Cruz, CA,
USA; 200 μg/ml); mouse anti-β-actin polyclonal antibody
(Bioworld; Louis Park, MN, USA; 1 mg/ml); rabbit anti-E-
cadherin polyclonal antibody (Bioworld; 1 mg/ml); rabbit
anti-vimentin monoclonal antibody (CST) and mouse anti-
MMP1 polyclonal antibody (Boster).
Immunofluorescence
The cells were pre-seeded onto sterile cover slips and
grown to 60% confluence, then fixed with 4% parafor-
maldehyde for 20 min, permeabilized with 0.2% Triton
X-100 (Sigma) for 15 min, and then incubated with nor-
mal goat serum and the primary antibodies at 4 °C over-
night. The cells were then washed with PBS, incubated
with the secondary antibody conjugated with TRITC
(Bioworld; Louis Park, MN, USA) (1:100) for 1 h and
subsequently incubated with DAPI (Beyotime, 1:1000)
for 5 min. The primary antibodies used were vimentin
(Cell Signaling, 1:200), cytokeratin (Bioworld, 1:200) and
HAS2 (Abcam, 1:200).
Knockdown of HAS2 expression by small interference
RNA
An HAS2-targeted small interference RNA (siRNA)
(Sigma, St. Louis, MO, USA) was used to obtain specific
suppression of HAS2 in CAFs. CAFs were permitted to
grow to 60% confluence and were infected with HAS2-
siRNA or a scrambled siRNA using Lipofectamine 2000
(Invitrogen) for 6 h according to the manufacturer’s in-
structions. The medium was then changed to complete
culture medium, and CAFs were permitted to grow for
another 48 h before being used for the experiments. The





Scramble siRNA, sense: 5’UUCUCCGAACGUGUCACG
UTT3’, antisense: 5’ACGUGACACGUUCGGAGAATT3’.
Collection of conditioned medium
When they achieved confluency, the corresponding cells
were re-suspended and counted, and 4 × 106 cells were
added to a 25 cm2 flask with 6 ml of FBS-free medium.
After incubation for 48 h, the conditioned medium was
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collected and used immediately. In the case of the
collection of the CM from CAFs that were treated with
4-MU (Sigma), which was dissolved and stored in
DMSO, the 4-MU was removed after 48 h of treatment
to avoid direct effects on the tumor cells.
Wound-healing and invasion assay
Cal27 cells were seeded in a 6-well plate and cultured in
growth medium until they reached 90% confluency. A
sterile pipette was used to produce a linear scratch on
the cell monolayer. After wounding, the non-adherent
cells and debris were carefully removed, and the cells
were incubated with either serum-free medium or CM
from either NFs or CAFs for 36 h. The migrated cells
were visualized in a specific region. The invasion assay
was performed using matrigel-coated transwell inserts.
A total of 5 × 104 Cal27 cells in 250 μl of serum-free
medium or in the CM from NFs or CAFs were seeded
into the upper chamber, and 750 μl of medium contain-
ing 10% FBS was added to the lower chamber to stimu-
late chemotaxis. After incubation for 36 h at 37 °C in 5%
CO2, the chambers were fixed in 4% paraformaldehyde
for 15 min, stained with 0.05% crystal violet for 15 min
and the numbers of cells in five random fields at 100×
magnification were counted using a microscope.
Bromodeoxyuridine (BrdU) assay
The cells were incubated for 24 h with 0.03 mg/ml BrdU
(Sigma), fixed with 4% paraformaldehyde containing
2 M HCl, blocked for 1 h with goat serum containing
0.5% Triton at 37 °C, and then incubated with BrdU
antibodies (1:300, Proteintech, USA) at 4 °C overnight.
Next, the cells were washed with PBS, incubated for
40 min with a secondary antibody labeled with Cy3 (Bio-
world, 1:100) and stained with DAPI. The BrdU-positive
cells in six randomly selected fields were counted using
a microscope at 200 ×.
RayBio antibody array
The medium supernatants were collected from NFs,
CAFs, scrambled siRNA-treated CAFs and HAS2 siRNA-
treated CAFs. All of these samples were evaluated by
RayBiotech Testing Services using the human MMP-
related antibody array (RayBio, Norcross, GA, USA).
Briefly, 1 ml of a 1:5 dilution of the sample was loaded
onto each cytokine membrane. The samples were incu-
bated overnight at 4 °C to allow the binding of the target
cytokines to the capture antibodies, followed by several
wash steps. A secondary biotin-labeled detection antibody
was added to bind to the captured antigens. The cytokine-
antibody-biotin complex was visualized by the addition of
FITC-conjugated avidin. The intensity of the signals was
quantified using the Axon GenePix laser scanner system.
QAH-MMP-1 software was used to analyze the cytokine
expression intensity. This program automatically com-
pares the fluorescence intensity of the samples to standard
curves to determine the concentrations of MMPs and
TIMPs. Only values within the valid interval were sub-
jected to statistical analysis. The valid intervals for all of
the targets are presented in Additional file 2: Table S2.
Statistical analysis
All data were analyzed using SPSS 17.0 software. Chi-
Square test or Fisher’s exact test was used to analyze the
data from the four-fold table in this article. Student’s t-test
was used to analyze the results from the RayBio Antibody
Array. One-way ANOVA was used to analyze the data
from the three groups described above, and the SNK
q-test was used for additional multiple comparisons if
necessary. A value of P < 0.05 was considered to be
statistically significant.
Results
HAS2 expression is higher in CAFs than in NFs
To determine the abundance of HAS isoforms in CAFs
from OSCCs and the paired NFs from the same patients,
fresh OSCC samples were acquired from three patients
by macroscopic dissection using the following morpho-
logical mapping: CAFs from the actual tumors were iso-
lated from the epicenter of the tumor tissue, and the
matched NFs were isolated from distal normal tissue lo-
cated at least 10 mm from the tumor margins. Three
pairs of matched CAFs and NFs were successfully iso-
lated and cultured in vitro as indicated by the fibroblast
characteristics including spindle-shaped morphology,
strong expression of the fibroblastic marker vimentin and
the absence of expression of the epithelial marker cytoker-
atin in each type of cells (Additional file 3: Figure S1a).
Meanwhile, strong expression of α-SMA, a key marker for
the identification of CAFs, was observed in CAFs but was
absent in NFs (Additional file 3: Figure S1b, c). Among
the three members of the HAS family, the abundance of
HAS2 were significantly enriched in CAFs. Importantly,
this isoform was also overexpressed in CAFs compared to
the matched NFs, whereas there were no differences be-
tween CAFs and NFs in the expression of HAS1 or HAS3
(Fig. 1a, b).
We next focused on HAS2 for further investigations.
In accordance with the PCR results, CAFs expressed a
markedly higher level of the HAS2 protein than NFs
(Fig. 1c). Consistent with this result, stronger HAS2
staining was visualized in the stromal fibroblasts from
the OSCC samples than in the normal tissue (Fig. 1d).
Although both the OSCC and the normal epithelium
showed HAS2 immunoreactivity, significant differences
in the HAS2 expression were only observed in the
stroma (P < 0.05) (Table 1). Together, these results sug-
gested that CAFs expressed higher levels of HAS2 and
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that HAS2 from the tumor stromal microenvironment
may be associated with tumorigenesis.
HAS2 expression is associated with OSCC progression
Although there is no specific marker for CAFs, α-SMA
has been widely used to characterize these cells [24]. To
further examine HAS2 expression in the α-SMA-positive
CAFs, we performed immunohistochemical staining on
serial sections. As shown in Fig. 2a, HAS2 expression
was positively correlated with that of α-SMA in the
tumor stroma, which implied that CAFs might be the
main source of HAS2 in the tumor stroma of the OSCC
(Fig. 2b). Notably, the abundance of stromal HAS2 was
found to be significantly correlated with advanced clin-
ical stages and cervical lymph node metastases (Table 2).
These findings indicated that the higher expression of
HAS2 in CAFs was associated with progression and
metastases of the OSCC.
CAFs promotes migration, invasion and EMT of OSCC
cells
Previous investigations have confirmed that CAFs fuel
the invasiveness and spreading of OSCC cells by direct
crosstalk or a paracrine process [3, 25, 26]. To evaluate
the role of paracrine effects, we treated Cal27 cells with
CAF- or NF-conditioned medium (CM). As expected,
the migration and invasion of the Cal27 cells were re-
markably enhanced after being cultured in CAF-CM
compared with NF-CM (Fig. 3a, c). We performed a
proliferation assay to exclude bystander effects due to
increased cell proliferation, which further verified that
CAF-CM enhanced the migration and invasion of the
Cal27 cells (Fig. 3b). CAF-CM also induced EMT in the
Cal27 cells, which was characterized by a remarkable de-
crease in the level of E-cadherin and increases in vimen-
tin, Twist and Snail. However, the matched NF-CM
failed to induce similar effects (Fig. 3d, e). Collectively,
these results suggest that CAFs from the tumor micro-
environment might promote the invasion and metastasis
cascades of the cancer cells by triggering the EMT
process in a paracrine manner.
Fig. 1 Higher expression of HAS2 in CAFs than in matched NFs. a The relative expression of HAS1, 2, 3 was measured by real-time PCR using
SYBR Green in three matched cell samples and displayed as the average of the 2-ΔΔCT values. b HAS2 expression was assayed by real-time PCR
using SYBR Green in three individual matched cell samples. c HAS2 expression was assayed by western blotting in three matched cell samples. d
HAS2 expression (brown color) in the OSCC and normal oral mucosa was examined by immunohistochemistry staining (400x magnification).
*p < 0.05 in (a) and (b). e: epithelia; M: stroma
Table 1 Differential expression of HAS2 in OSCC and normal
oral mucosa
Epithelia P value Stroma P value
cancer normal cancer normal
HAS2(High) 45 15 1.000 25 2 0.008
HAS2(Low) 3 1 23 14
Bold values signify P value < 0.05. Fisher’s exact test
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Knocking down HAS2 decreases CAF-induced migration,
invasion and EMT of the OSCC cells
To assess whether HAS2 participated in CAF-induced
migration, invasion and EMT of cancer cells, CAFs were
transfected with HAS2-specific siRNA or a scrambled
siRNA. As expected, the efficiency of knockdown of
HAS2 was above 75% for two HAS2-targeted siRNAs
(#1 and #2) (Additional file 4: Figure S2a). HAS2 knock-
down neither impacted the expression of HAS1 and
HAS3, nor the proliferation and apoptosis of CAFs
(Additional file 4: Figure S2a–c). The knockdown of
HAS2 in CAFs was confirmed by western blotting and
immunofluorescence (Fig. 4a, b). Compared with the
scrambled siRNA and the control, HAS2 depletion robustly
attenuated CAF-induced migration and invasion of the
Cal27 cells (Fig. 4c, d), which suggested that knocking down
HAS2 ameliorated CAF-derived paracrine stimulation of
the Cal27 cell behaviors. Similarly, knocking down
HAS2 in CAFs prevented the EMT-associated pheno-
typic changes in the Cal27 cells that were induced by
CAFs (Fig. 4e, f ). These findings suggest that HAS2
might be a key mediator that is involved in the
process of CAF-promoted OSCC progression.
An HAS inhibitor suppresses CAF-induced migration,
invasion and EMT of OSCC cells
To further explore the roles of CAF-derived HAS2 in
cancer cell migration and invasion, the HA synthesis in-
hibitor 4-methylumbelliferone (4-MU) was used to eluci-
date the underlying mechanism. First, we determined
the concentration of 4-MU appropriate for the exposure
of CAFs. Our results showed that the cell viability did
not change significantly when 4-MU was added at con-
centrations less than 0.4 mM but declined at higher con-
centrations (Fig. 5a). The expression of HAS2 was
potently inhibited when more than 0.4 mM 4-MU was
added (Fig. 5b, c). Thus, we chose 0.4 mM as an appro-
priate concentration in the following experiments. As
shown in Fig. 5d and e, the migration and invasion of
the Cal27 cells was enhanced when they were cultured
with CAF-CM. However, this effect was greatly attenu-
ated when 4-MU was added. Furthermore, the increases
in the EMT markers of the Cal27 cells were partially ab-
rogated following 4-MU exposure (Fig. 5f, g).
HAS2 regulates CAF-promoted OSCC progression by
altering the balance of MMP1 and TIMP1
Mounting evidence has demonstrated that MMP family
members are critically involved in tumor invasion and
Fig. 2 Positive association of the expression of HAS2 and α-SMA in OSCC. a Within serial sections of the same tissue, the expression of HAS2 and
α-SMA (brown color) was showed by immunohistochemistry staining (400x magnification). b Qualitative staining scores of HAS2 and α-SMA in a
total of 48 tumor samples
Table 2 Relation between HAS2, α-SMA expression levels and
clinicopathological variables
Variable HAS2 α-SMA
High Low P value High Low P value
HD 1.000 0.777
I 15 13 14 14
II + III 10 10 9 11
TNM status 0.021 0.000
I + II 8 15 5 18
III + IV 17 8 18 7
PLN status 0.020 0.038
Negative 11 18 10 19
Positive 14 5 13 6
α-SMA, α-smooth muscle actin; HD histological differentiation, TNM tumor-node-
metastases, PLN pathologic lymph node. Bold values signify P value < 0.05.
Chi-Square test
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EMT and that they are valuable factors for the diagnosis
and prognosis of OSCC patients. Totals of seven mem-
bers of the MMP family and three members of the TIMP
family were measured using the RayBio Human MMP-
Related Antibody Array (Fig. 6a). We first evaluated the
supernatant media from NFs and CAFs and found that
compared to NFs, CAFs expressed higher levels of
MMP1 and MMP3 and lower levels of MMP10 and
TIMP1 (Fig. 6b, c). To elucidate the role of HAS2 in the
regulation of MMPs and TIMPs, we examined the
supernatant of the media from CAFs with/without
HAS2 knockdown. The results showed that knocking
down HAS2 remarkably decreased the MMP1 level and
increased the TIMP1 level in the media from CAFs, but
the changes in MMP3 and MMP10 were not significant
(Fig. 6d, e). To further confirm the potential roles of
MMP1 and TIMP1 in CAFs, three paired sets of CAFs
and NFs were examined by western blotting, and the
level of MMP1 was higher in CAFs than in the matched
NFs whereas TIMP1 showed the opposite pattern
(Fig. 6f). As expected, knocking down HAS2 remarkably
decreased the expression of MMP1 and increased the ex-
pression of TIMP1 in CAFs (Fig. 6f). Collectively, these
results indicated that HAS2 led to disturbances in the
levels of MMP1 and TIMP1 which may, at least in part,
be responsible for CAF-promoted OSCC progression.
Discussion
In the current study, we provided novel evidence that
CAFs expressed higher levels of HAS2 than the paired
NFs. We also revealed that HAS2, which is expressed by
CAFs, plays a potential role in promoting the invasion of
oral cancer cells. Importantly, we clarified the pivotal
role of HAS2, which probably led to disruption in the
expression of MMP1 and TIMP1 and consequently pro-
moted cancer progression. Our findings extend the
current understanding of the molecular mechanisms
underlying the tumor-promoting functions of CAFs.
CAFs are the primary stromal cell type. These cells
promote cancer progression through the secretion of
growth factors, matrix-degrading enzymes, and pro-
angiogenic factors in various solid cancer types [27–30].
Fig. 3 CAFs promoted migration, invasion and EMT of Cal27 cells. a Representative images of CAF-CM promoting Cal27 cell migration compared
to control and NFs-CM for 36 h incubation. b Representative images of Cal27 cell proliferation by BrdU incorporation assay after treated with
CAFs-CM or NFs-CM. c The cells invading the filters coated with the Matrigel after 36 h (upper panel); and the quantification of the cell invasion in
five randomly chosen fields (bottom panel). d The expression of EMT-associated genes E-cad, Vimentin, Twist, and Snail was measured by real-time
PCR using SYBR Green. e The expression of E-cad and Vimentin was measured using western blotting. *p < 0.05; #p > 0.05 in (c) and (d). CM:
conditioned medium
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In this study, we further characterized CAFs from OSCC
in vitro and in vivo and provided the first evidence for a
significant role for HAS2 from CAFs in promoting the
EMT, invasion and metastases of OSCC. Two distinct
CAF subtypes have been shown to promote the invasion
of tumor cells by different mechanisms including a high
production of hyaluronan or the synthesis of TGF-β1
[27]. Although the role of CAF-derived TGF-β1 in pro-
moting tumor progression has been well studied, the
role of CAF-derived hyaluronan in this progression re-
mains largely unexplored [31]. Our data clearly showed
that the HAS2 level is associated with CAF-mediated
promotion of the migration, invasion and EMT of the
OSCC cells. These results suggested a pivotal role of
CAF-derived hyaluronan in promoting tumor progres-
sion. However, more studies are needed to investigate
the function of the specific hyaluronan that is synthe-
sized by HAS2.
The overexpression of HAS2 has been observed in
some solid cancers in which it is associated with more
aggressive tumor phenotypes [30–34]. However, it is still
largely unknown whether there is a correlation between
the HAS2 expression levels in CAFs and tumor aggres-
siveness. Although there is no specific marker for CAFs,
α-SMA has been widely used to characterize these cells
[9]. In our study, we found that HAS2 expression was
consistently associated with the α-SMA-positive myofi-
broblasts in the stroma of OSCC and both of these were
significantly correlated with advanced clinic stages and
cervical lymph node metastasis. These findings extend
the previous knowledge that CAF-derived HAS2 pro-
motes oral cancer progression.
Cancers have sometimes been described as resembling
chronically unhealed wounds, and myofibroblasts may be
essential for the invasive growth and associated with poor
prognosis [35]. Our data revealed that CAFs expressed a
higher level of HAS2 than NFs and that HAS2 was posi-
tively correlated with α-SMA. Indeed, HA generation is
essential for persistence of myofibroblast phenotype in
lung fibroblasts, and HA deprivation by inhibition of
Fig. 4 Knocking down HAS2 in CAFs reduced the migration, invasion and EMT of the Cal27 cells. The expression of HAS2 was evaluated in CAFs
that had been transfected with a scrambled siRNA or an HAS2-targeted siRNA by western blotting (a) and immunofluorescence (b). Representative
images of the migration (c) and invasion (d) of the Cal27 cells that were cultured with CM from CAFs, CAFs with a scrambled siRNA or CAFs with
HAS2-targeted siRNA for 36 h. e The expression of EMT-associated genes was measured by real-time PCR using SYBR Green. f The expression of E-cad
and Vimentin was analyzed using western blotting. *p < 0.05; #p > 0.05 in (d) and (e). Bars in (b): 100 μm. siRNA: short interfering RNA; CM:
conditioned medium
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HAS2 reduces the expression of α-SMA [18]. Furthermore,
over-expression of HAS2 in oral fibroblasts modifies their
response to TGF-β1 [36]. These data imply that CAFs in
oral cancer may secrete a larger amount of HA by over-
expressing HAS2 to maintain their phenotype. Future stud-
ies should address whether cytokines or growth factors
such as TGF-β1, PDGF and IL-1β in the tumor environ-
ment [37–40] contribute to activating quiescent fibroblasts.
Fig. 5 Treatment of CAFs with 4-MU reduced the migration, invasion and EMT of the Cal27 cells. a The viability of CAFs after 48 h of treatment
with various concentration of 4-MU assessed as the OD following the MTT assay. b The levels of the HAS isoforms in CAFs after 48 h of treatment
with various concentration of 4-MU were measured by real-time PCR using SYBR Green. and shown as the average 2-ΔΔCT values. c The expression
of HAS2 in CAFs cultured with various concentrations of 4-MU was determined by western blotting. d Representative images of the migration (d)
and invasion (e) of Cal27 cells cultured with serum-free medium, CM from CAFs, or CM from CAFs that had been treated with 0.4 mM 4-MU. f
The expression of EMT-associated genes was measured by real-time PCR using SYBR Green. g The expression of E-cad and Vimentin was examined
by western blotting. *p < 0.05; #p > 0.05 in (a), (e) and (f). 4-MU: 4-Methylumbelliferone; CM: conditioned medium
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Our findings confirm that the HAS2-mediated
MMP1 and TIMP1 changes are most likely respon-
sible for the mechanisms underlying CAF-mediated
promotion of the migration, invasion and EMT of
oral cancer cells. The mechanism for CAF-induced
EMT of cancer cells has been well explained by evi-
dence that the TIMP family members control the
ECM integrity and cell surface protein landscape
through post-translational inhibition of MMPs [41]. In
our study, we found that Cal27 cells undergo the
EMT process when cultured in CAF-CM, and the
EMT phenotype could be blocked when HAS2 of
CAFs was knocked down or when the cells were treated
with an HAS inhibitor. Of note, HAS2-mediated
downregulation of TIMP1 may be responsible for the
phenotypic changes of the CAFs. TIMP loss in fibro-
blasts elicits the myofibroblast phenotype that is
associated with the conversion of stromal fibroblasts
into CAFs [42]. TIMP-knockout fibroblasts release
metalloproteinase activity within the tumor-stromal com-
partment. These experiments showed that complete
TIMP loss is sufficient for the acquisition of CAFs
functions [38]. In accordance with these findings, we
found that TIMP1 expression was lower in CAFs than
in the matched NFs and that knocking down HAS2
rescued TIMP1 expression and CAF function. Further
studies are needed to elucidate how HAS2 mediates
TIMP1 expression.
Conclusions
In summary, the data presented here demonstrate that
HAS2, which is expressed by CAFs, may facilitate the
migration, invasion and EMT of oral cancer cells by dis-
turbing the balance between MMP1 and TIMP1. Thus,
Fig. 6 The expression of MMP1 and TIMP1 is regulated by HAS2. a General scheme of the application of the samples; POS1 and 2 represent the
positive controls. b Fluorescent images of the antibody assays for NFs and CAFs. c The fluorescence intensity was automatically compared to
standard curves and was translated into the absolute concentration values in b. d Fluorescent images of the antibody assays for CAFs with
scramble and CAFs with HAS2-siRNA. e The fluorescence intensity was translated into the absolute concentration values in d. f The expression of
MMP1 and TIMP1 was analyzed using western blotting. *p < 0.05; #p > 0.05 in (c) and (e)
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CAF-derived HAS2 may be a new therapeutic target
against oral cancer.
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